Page last updated: 2024-10-26

donepezil and CJD (Creutzfeldt-Jakob Disease)

donepezil has been researched along with CJD (Creutzfeldt-Jakob Disease) in 1 studies

Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ukai, K1
Matsuo, K1
Nakamura, R1
Sobue, G1
Kosaka, K1
Shibayama, H1
Iritani, S1
Ishihara, R1
Ozaki, N1

Other Studies

1 other study available for donepezil and CJD (Creutzfeldt-Jakob Disease)

ArticleYear
A case of dementia with Lewy bodies that temporarily showed symptoms similar to Creutzfeldt-Jakob disease.
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2010, Volume: 10, Issue:4

    Topics: Aged; Brain Ischemia; Cholinesterase Inhibitors; Creutzfeldt-Jakob Syndrome; Diagnosis, Differential

2010